TELA - יחס חוב להיוון בספרים telabio.com

Global certification challenges and electronics supply chain disruptions from Asia are weighing on the operations of TELA Bio, Inc. (TELA). The debt-to-book capitalization financing structure illustrates this trend, where 0.00 shows the current value of the metric. While the slow adoption of new materials and insurance adjustments create barriers, the release of biosynthetic implants is helping the company effectively expand its market share.

This indicator determines the proportion between total borrowings and the value of equity. By analyzing the ratio of financial debt to book capitalization, an investor assesses the stability of the financing structure. The ratio shows the company's degree of dependence on creditors relative to its net assets. For TELA Bio, Inc. (TELA), a low level of this parameter confirms financial autonomy. This allows management to seamlessly implement innovative regenerative materials, displacing synthetic analogs.